Activity of Mesenchymal Stem Cells in Therapies for Chronic Skin Wound Healing

Overview

Journal Organogenesis

Specialties Anatomy & Histology
Biology
Biotechnology

Date 2013 Dec 11

PMID 24322872

Citations 79

Authors

Austin Nuschke

Affiliations

Soon will be listed here.

Abstract

Chronic or non-healing skin wounds present an ongoing challenge in advanced wound care, particularly as the number of patients increases while technology aimed at stimulating wound healing in these cases remains inefficient. Mesenchymal stem cells (MSCs) have proved to be an attractive cell type for various cell therapies due to their ability to differentiate into various cell lineages, multiple donor tissue types, and relative resilience in ex-vivo expansion, as well as immunomodulatory effects during transplants. More recently, these cells have been targeted for use in strategies to improve chronic wound healing in patients with diabetic ulcers or other stasis wounds. Here, we outline several mechanisms by which MSCs can improve healing outcomes in these cases, including reducing tissue inflammation, inducing angiogenesis in the wound bed, and reducing scarring following the repair process. Approaches to extend MSC life span in implant sites are also examined.

Citing Articles

Micro-fragmented adipose tissue-An innovative therapeutic approach: A narrative review.

Fu H, Wang C Medicine (Baltimore). 2025; 104(9):e41724.

PMID: 40020111 PMC: 11875617. DOI: 10.1097/MD.0000000000041724.

Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective.

Razavi Z, Aliniay Sharafshadehi S, Yousefi M, Javaheri F, Rahimi Barghani M, Afkhami H Arch Dermatol Res. 2025; 317(1):320.

PMID: 39888392 DOI: 10.1007/s00403-024-03790-8.

Current Status of Biomedical Products for Gene and Cell Therapy of Recessive Dystrophic Epidermolysis Bullosa.

Zorina A, Zorin V, Isaev A, Kudlay D, Manturova N, Ustugov A Int J Mol Sci. 2024; 25(19).

PMID: 39408598 PMC: 11476579. DOI: 10.3390/ijms251910270.

Host-Microbiome Crosstalk in Chronic Wound Healing.

Mihai M, Balaceanu-Gurau B, Ion A, Holban A, Gurau C, Popescu M Int J Mol Sci. 2024; 25(9).

PMID: 38731848 PMC: 11083077. DOI: 10.3390/ijms25094629.

Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications.

Shi Y, Yang X, Min J, Kong W, Hu X, Zhang J Front Endocrinol (Lausanne). 2024; 15:1343255.

PMID: 38681772 PMC: 11045945. DOI: 10.3389/fendo.2024.1343255.

References

Tang Y, Cai B, Yuan F, He X, Lin X, Wang J . Melatonin Pretreatment Improves the Survival and Function of Transplanted Mesenchymal Stem Cells after Focal Cerebral Ischemia. Cell Transplant. 2013; 23(10):1279-1291. DOI: 10.3727/096368913x667510. View

Prochazka V, Gumulec J, Jaluvka F, Salounova D, Jonszta T, Czerny D . Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant. 2010; 19(11):1413-24. PMC: 5478382. DOI: 10.3727/096368910X514170. View

Chong P, Selvaratnam L, Abbas A, Kamarul T . Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res. 2011; 30(4):634-42. DOI: 10.1002/jor.21556. View

Galiano R, Tepper O, Pelo C, Bhatt K, Callaghan M, Bastidas N . Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol. 2004; 164(6):1935-47. PMC: 1615774. DOI: 10.1016/S0002-9440(10)63754-6. View

Fan V, Tamama K, Au A, Littrell R, Richardson L, Wright J . Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells. 2007; 25(5):1241-51. DOI: 10.1634/stemcells.2006-0320. View

Pereira R, Halford K, OHara M, Leeper D, Sokolov B, Pollard M . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995; 92(11):4857-61. PMC: 41806. DOI: 10.1073/pnas.92.11.4857. View

Murphy P, Evans G . Advances in wound healing: a review of current wound healing products. Plast Surg Int. 2012; 2012:190436. PMC: 3335515. DOI: 10.1155/2012/190436. View

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

Senel O, Cetinkale O, Ozbay G, Ahcioglu F, Bulan R . Oxygen free radicals impair wound healing in ischemic rat skin. Ann Plast Surg. 1997; 39(5):516-23. DOI: 10.1097/00000637-199711000-00012. View

10.

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

11.

Bensaid W, Triffitt J, Blanchat C, Oudina K, Sedel L, Petite H . A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003; 24(14):2497-502. DOI: 10.1016/s0142-9612(02)00618-x. View

12.

Conway K, Ruge F, Price P, Harding K, Jiang W . Hepatocyte growth factor regulation: an integral part of why wounds become chronic. Wound Repair Regen. 2007; 15(5):683-92. DOI: 10.1111/j.1524-475X.2007.00296.x. View

13.

Phinney D, Kopen G, Righter W, Webster S, Tremain N, Prockop D . Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem. 1999; 75(3):424-36. View

14.

Nissen N, Polverini P, Koch A, Volin M, Gamelli R, DiPietro L . Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 1998; 152(6):1445-52. PMC: 1858442. View

15.

Turner J, Cho Y, Dinh N, Waring A, Lehrer R . Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998; 42(9):2206-14. PMC: 105778. DOI: 10.1128/AAC.42.9.2206. View

16.

Stadelmann W, Digenis A, Tobin G . Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998; 176(2A Suppl):26S-38S. DOI: 10.1016/s0002-9610(98)00183-4. View

17.

Schafer M, Werner S . Oxidative stress in normal and impaired wound repair. Pharmacol Res. 2008; 58(2):165-71. DOI: 10.1016/j.phrs.2008.06.004. View

18.

Naughton G, Mansbridge J, Gentzkow G . A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs. 1998; 21(11):1203-10. DOI: 10.1111/j.1525-1594.1997.tb00476.x. View

19.

Rodrigues M, Yates C, Nuschke A, Griffith L, Wells A . The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A. 2013; 19(17-18):1972-83. PMC: 3725854. DOI: 10.1089/ten.TEA.2012.0568. View

20.

Krisp C, Jacobsen F, McKay M, Molloy M, Steinstraesser L, Wolters D . Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics. 2013; 13(17):2670-81. DOI: 10.1002/pmic.201200502. View